Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
1.950
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Climb Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -69.12 | -35.12 | -45.24 | -47.48 | -20.67 | -6.55 |
| Asset Writedown & Restructuring Costs | 51.66 | 0.18 | - | - | 9.16 | 2.75 |
| Loss (Gain) From Sale of Investments | -0.58 | -2.33 | -0.18 | 0.37 | - | - |
| Stock-Based Compensation | 5.1 | 12.81 | 6.99 | 3.74 | 0.71 | - |
| Other Operating Activities | 0.51 | 0.1 | 0.85 | 11.47 | -0.36 | -0.9 |
| Change in Accounts Payable | -2.05 | -0.69 | -0.65 | 0.32 | -0.02 | 0.02 |
| Change in Other Net Operating Assets | 3.5 | 4.45 | 0.86 | -4.49 | -2.91 | -0.33 |
| Operating Cash Flow | -10.99 | -20.6 | -37.37 | -36.07 | -14.1 | -5.01 |
| Cash Acquisitions | -4.65 | - | - | - | 8.28 | - |
| Sale (Purchase) of Intangibles | - | - | - | - | -0.2 | - |
| Investment in Securities | -21.29 | 68.98 | 34.44 | -114.97 | - | - |
| Investing Cash Flow | -30.94 | 68.98 | 34.44 | -114.97 | 8.08 | - |
| Issuance of Common Stock | 130.98 | 0.84 | - | 83.29 | - | - |
| Financing Cash Flow | 130.98 | 0.84 | - | 177.23 | 4.93 | 26.24 |
| Foreign Exchange Rate Adjustments | -0.23 | 0.3 | -0.41 | 0.25 | 0.36 | -0.01 |
| Net Cash Flow | 88.82 | 49.53 | -3.34 | 26.44 | -0.74 | 21.22 |
| Free Cash Flow | -10.99 | -20.6 | -37.37 | -36.07 | -14.1 | -5.01 |
| Free Cash Flow Per Share | -0.29 | -0.76 | -1.42 | -2.94 | -6.44 | -3.02 |
| Levered Free Cash Flow | -5.26 | 3.46 | -20.51 | -25.3 | -6.57 | - |
| Unlevered Free Cash Flow | -5.26 | 3.46 | -20.51 | -25.3 | -6.57 | - |
| Change in Net Working Capital | -1.61 | -4.07 | -0.71 | 6.74 | -0.28 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.